Pathstone Holdings, LLC Repligen Corp Transaction History
Pathstone Holdings, LLC
- $25.3 Billion
- Q2 2025
A detailed history of Pathstone Holdings, LLC transactions in Repligen Corp stock. As of the latest transaction made, Pathstone Holdings, LLC holds 22,568 shares of RGEN stock, worth $2.74 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
22,568
Previous 34,506
34.6%
Holding current value
$2.74 Million
Previous $4.39 Million
36.06%
% of portfolio
0.01%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding RGEN
# of Institutions
500Shares Held
58.2MCall Options Held
125KPut Options Held
534K-
Black Rock Inc. New York, NY7.57MShares$919 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.6MShares$802 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$616 Million0.01% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.91MShares$232 Million0.53% of portfolio
-
State Street Corp Boston, MA1.62MShares$197 Million0.01% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $6.74B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....